4.5 Article

Global transgenic upregulation of KCC2 confers enhanced diazepam efficacy in treating sustained seizures

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality

Wolfgang Loescher et al.

Summary: This response corrects the inaccurate descriptions of the model and data in a recent study on the pharmacology of neonatal seizures in a novel rat model of birth asphyxia by Ben-Ari and Delpire. The authors also address the implications of bumetanide actions on neurons in other brain disorders due to its poor brain penetration and wide cellular expression patterns of the target protein NKCC1.

EPILEPSIA (2021)

Article Multidisciplinary Sciences

KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition

Vincent Magloire et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures

Yvonne E. Moore et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

KCC2 downregulation facilitates epileptic seizures

Lulan Chen et al.

SCIENTIFIC REPORTS (2017)

Article Neurosciences

The Contribution of Raised Intraneuronal Chloride to Epileptic Network Activity

Hannah Alfonsa et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Biochemistry & Molecular Biology

Chloride extrusion enhancers as novel therapeutics for neurological diseases

Martin Gagnon et al.

NATURE MEDICINE (2013)

Article Behavioral Sciences

Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo

Doris D. Wang et al.

EPILEPSY & BEHAVIOR (2012)

Article Medicine, General & Internal

A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus

BK Alldredge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)